Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Development of a preliminary essential medicines list for Canada.

CMAJ open

Taglione MS, Ahmad H, Slater M, Aliarzadeh B, Glazier RH, Laupacis A, Persaud N.
PMID: 28401130
CMAJ Open. 2017 Feb 16;5(1):E137-E143. doi: 10.9778/cmajo.20160122. eCollection 2017.

BACKGROUND: Some evidence supports the use of a short list of essential medicines to improve prescribing. We aimed to create a preliminary essential medicines list for use in Canada.METHODS: The 2013 World Health Organization Model List of Essential Medicines...

Cite
Taglione MS, Ahmad H, Slater M, et al. Development of a preliminary essential medicines list for Canada. CMAJ Open. 2017;5(1):E137-E143doi: 10.9778/cmajo.20160122.
Taglione, M. S., Ahmad, H., Slater, M., Aliarzadeh, B., Glazier, R. H., Laupacis, A., & Persaud, N. (2017). Development of a preliminary essential medicines list for Canada. CMAJ open, 5(1), E137-E143. https://doi.org/10.9778/cmajo.20160122
Taglione, Michael S, et al. "Development of a preliminary essential medicines list for Canada." CMAJ open vol. 5,1 (2017): E137-E143. doi: https://doi.org/10.9778/cmajo.20160122
Taglione MS, Ahmad H, Slater M, Aliarzadeh B, Glazier RH, Laupacis A, Persaud N. Development of a preliminary essential medicines list for Canada. CMAJ Open. 2017 Feb 16;5(1):E137-E143. doi: 10.9778/cmajo.20160122. eCollection 2017. PMID: 28401130; PMCID: PMC5378503.
Copy Download .nbib Format: NLM
The effects of an 'explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy.

Health expectations : an international journal of public participation in health care and health policy

O'Connor AM, Wells GA, Tugwell P, Laupacis A, Elmslie T, Drake E.
PMID: 11281872
Health Expect. 1999 Mar;2(1):21-32. doi: 10.1046/j.1369-6513.1999.00027.x.

OBJECTIVE: To evaluate the incremental effect of a graphic weigh-scale values clarification exercise to explicitly consider the personal importance of the benefits versus the risks in a woman's decision aid regarding postmenopausal hormone therapy. DESIGN: Randomized controlled trial. Intervention...

Cite
O'Connor AM, Wells GA, Tugwell P, et al. The effects of an 'explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy. Health Expect. 1999;2(1):21-32doi: 10.1046/j.1369-6513.1999.00027.x.
O'Connor, A. M., Wells, G. A., Tugwell, P., Laupacis, A., Elmslie, T., & Drake, E. (1999). The effects of an 'explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy. Health expectations : an international journal of public participation in health care and health policy, 2(1), 21-32. https://doi.org/10.1046/j.1369-6513.1999.00027.x
O'Connor, Annette M., et al. "The effects of an 'explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy." Health expectations : an international journal of public participation in health care and health policy vol. 2,1 (1999): 21-32. doi: https://doi.org/10.1046/j.1369-6513.1999.00027.x
O'Connor AM, Wells GA, Tugwell P, Laupacis A, Elmslie T, Drake E. The effects of an 'explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy. Health Expect. 1999 Mar;2(1):21-32. doi: 10.1046/j.1369-6513.1999.00027.x. PMID: 11281872; PMCID: PMC5061405.
Copy Download .nbib Format: NLM
Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs.

Evidence-based medicine

Laupacis A.
PMID: 17213165
Evid Based Med. 2006 Dec;11(6):171. doi: 10.1136/ebm.11.6.171.

No abstract available.

Cite
Laupacis A. Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs. Evid Based Med. 2006;11(6):171doi: 10.1136/ebm.11.6.171.
Laupacis, A. (2006). Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs. Evidence-based medicine, 11(6), 171. https://doi.org/10.1136/ebm.11.6.171
Laupacis, Andreas. "Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs." Evidence-based medicine vol. 11,6 (2006): 171. doi: https://doi.org/10.1136/ebm.11.6.171
Laupacis A. Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs. Evid Based Med. 2006 Dec;11(6):171. doi: 10.1136/ebm.11.6.171. PMID: 17213165.
Copy Download .nbib Format: NLM
Clinical prediction rules for children: a systematic review.

Pediatrics

Maguire JL, Kulik DM, Laupacis A, Kuppermann N, Uleryk EM, Parkin PC.
PMID: 21859912
Pediatrics. 2011 Sep;128(3):e666-77. doi: 10.1542/peds.2011-0043. Epub 2011 Aug 22.

CONTEXT: The degree to which clinical prediction rules (CPRs) for children meet published standards is unclear.OBJECTIVE: To systematically review the quality, performance, and validation of published CPRs for children, compare them with adult CPRs, and suggest pediatric-specific changes to...

Cite
Maguire JL, Kulik DM, Laupacis A, et al. Clinical prediction rules for children: a systematic review. Pediatrics. 2011;128(3):e666-77doi: 10.1542/peds.2011-0043.
Maguire, J. L., Kulik, D. M., Laupacis, A., Kuppermann, N., Uleryk, E. M., & Parkin, P. C. (2011). Clinical prediction rules for children: a systematic review. Pediatrics, 128(3), e666-77. https://doi.org/10.1542/peds.2011-0043
Maguire, Jonathon L, et al. "Clinical prediction rules for children: a systematic review." Pediatrics vol. 128,3 (2011): e666-77. doi: https://doi.org/10.1542/peds.2011-0043
Maguire JL, Kulik DM, Laupacis A, Kuppermann N, Uleryk EM, Parkin PC. Clinical prediction rules for children: a systematic review. Pediatrics. 2011 Sep;128(3):e666-77. doi: 10.1542/peds.2011-0043. Epub 2011 Aug 22. PMID: 21859912.
Copy Download .nbib Format: NLM
Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding.

Current oncology (Toronto, Ont.)

Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, Chan KKW.
PMID: 29089796
Curr Oncol. 2017 Oct;24(5):295-301. doi: 10.3747/co.24.3648. Epub 2017 Oct 25.

BACKGROUND: The pan-Canadian Oncology Drug Review (pcodr) was implemented in 2011 to address uneven drug coverage and lack of transparency with respect to the various provincial cancer drug review processes in Canada. We evaluated the impact of the pcodr...

Cite
Srikanthan A, Mai H, Penner N, et al. Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding. Curr Oncol. 2017;24(5):295-301doi: 10.3747/co.24.3648.
Srikanthan, A., Mai, H., Penner, N., Amir, E., Laupacis, A., Sabharwal, M., & Chan, K. K. W. (2017). Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding. Current oncology (Toronto, Ont.), 24(5), 295-301. https://doi.org/10.3747/co.24.3648
Srikanthan, A, et al. "Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding." Current oncology (Toronto, Ont.) vol. 24,5 (2017): 295-301. doi: https://doi.org/10.3747/co.24.3648
Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, Chan KKW. Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding. Curr Oncol. 2017 Oct;24(5):295-301. doi: 10.3747/co.24.3648. Epub 2017 Oct 25. PMID: 29089796; PMCID: PMC5659150.
Copy Download .nbib Format: NLM
Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial.

JAMA internal medicine

Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A.
PMID: 31589276
JAMA Intern Med. 2019 Oct 07; doi: 10.1001/jamainternmed.2019.4472. Epub 2019 Oct 07.

IMPORTANCE: Nonadherence to treatment with medicines is common globally, even for life-saving treatments. Cost is one important barrier to access, and only some jurisdictions provide medicines at no charge to patients.OBJECTIVE: To determine whether providing essential medicines at no...

Cite
Persaud N, Bedard M, Boozary AS, et al. Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial. JAMA Intern Med. 2019;doi: 10.1001/jamainternmed.2019.4472.
Persaud, N., Bedard, M., Boozary, A. S., Glazier, R. H., Gomes, T., Hwang, S. W., Jüni, P., Law, M. R., Mamdani, M. M., Manns, B. J., Martin, D., Morgan, S. G., Oh, P. I., Pinto, A. D., Shah, B. R., Sullivan, F., Umali, N., Thorpe, K. E., Tu, K., Laupacis, A. (2019). Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial. JAMA internal medicine, . https://doi.org/10.1001/jamainternmed.2019.4472
Persaud, Navindra, et al. "Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial." JAMA internal medicine vol. (2019). doi: https://doi.org/10.1001/jamainternmed.2019.4472
Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A. Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial. JAMA Intern Med. 2019 Oct 07; doi: 10.1001/jamainternmed.2019.4472. Epub 2019 Oct 07. PMID: 31589276; PMCID: PMC6784757.
Copy Download .nbib Format: NLM
[No title available]

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Laupacis A.
PMID: 33051328
CMAJ. 2020 Oct 13;192(41):E1248-E1249. doi: 10.1503/cmaj.200428-f.

No abstract available.

Cite
Laupacis A. Travailler ensemble à contenir et gérer la COVID-19. . CMAJ. 2020;192(41):E1248-E1249doi: 10.1503/cmaj.200428-f.
Laupacis, A. (2020). Travailler ensemble à contenir et gérer la COVID-19. . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 192(41), E1248-E1249. https://doi.org/10.1503/cmaj.200428-f
Laupacis, Andreas. "Travailler ensemble à contenir et gérer la COVID-19." . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 192,41 (2020): E1248-E1249. doi: https://doi.org/10.1503/cmaj.200428-f
Laupacis A. Travailler ensemble à contenir et gérer la COVID-19. . CMAJ. 2020 Oct 13;192(41):E1248-E1249. doi: 10.1503/cmaj.200428-f. French. PMID: 33051328; PMCID: PMC7588245.
Copy Download .nbib Format: NLM
[No title available]

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Holroyd-Leduc JM, Laupacis A.
PMID: 33139434
CMAJ. 2020 Nov 02;192(44):E1389-E1390. doi: 10.1503/cmaj.201017-f.

No abstract available.

Cite
Holroyd-Leduc JM, Laupacis A. Soins continus et COVID-19 : Qu’une telle tragédie ne se reproduise plus au Canada! . CMAJ. 2020;192(44):E1389-E1390doi: 10.1503/cmaj.201017-f.
Holroyd-Leduc, J. M., & Laupacis, A. (2020). Soins continus et COVID-19 : Qu’une telle tragédie ne se reproduise plus au Canada! . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 192(44), E1389-E1390. https://doi.org/10.1503/cmaj.201017-f
Holroyd-Leduc, Jayna M, and Laupacis, Andreas. "Soins continus et COVID-19 : Qu’une telle tragédie ne se reproduise plus au Canada!" . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 192,44 (2020): E1389-E1390. doi: https://doi.org/10.1503/cmaj.201017-f
Holroyd-Leduc JM, Laupacis A. Soins continus et COVID-19 : Qu’une telle tragédie ne se reproduise plus au Canada! . CMAJ. 2020 Nov 02;192(44):E1389-E1390. doi: 10.1503/cmaj.201017-f. French. PMID: 33139434; PMCID: PMC7647478.
Copy Download .nbib Format: NLM
Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohort.

BMJ open

Vyas MV, Fang J, Austin PC, Laupacis A, Cheung MC, Silver FL, Kapral MK.
PMID: 34728439
BMJ Open. 2021 Nov 02;11(11):e046377. doi: 10.1136/bmjopen-2020-046377.

OBJECTIVES: To evaluate the association between immigration status and all-cause mortality in different disease cohorts, and the impact of loss to follow-up on the observed associations.DESIGN: Population-based retrospective cohort study using linked administrative health data in Ontario, Canada.SETTING: We...

Cite
Vyas MV, Fang J, Austin PC, et al. Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohort. BMJ Open. 2021;11(11):e046377doi: 10.1136/bmjopen-2020-046377.
Vyas, M. V., Fang, J., Austin, P. C., Laupacis, A., Cheung, M. C., Silver, F. L., & Kapral, M. K. (2021). Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohort. BMJ open, 11(11), e046377. https://doi.org/10.1136/bmjopen-2020-046377
Vyas, Manav V, et al. "Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohort." BMJ open vol. 11,11 (2021): e046377. doi: https://doi.org/10.1136/bmjopen-2020-046377
Vyas MV, Fang J, Austin PC, Laupacis A, Cheung MC, Silver FL, Kapral MK. Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohort. BMJ Open. 2021 Nov 02;11(11):e046377. doi: 10.1136/bmjopen-2020-046377. PMID: 34728439; PMCID: PMC8565574.
Copy Download .nbib Format: NLM
SARS-CoV-2 vaccination should be required to practise medicine in Canada.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

McRae AD, Laupacis A.
PMID: 34753806
CMAJ. 2021 Nov 29;193(47):E1816-E1817. doi: 10.1503/cmaj.211839. Epub 2021 Nov 09.

No abstract available.

Cite
McRae AD, Laupacis A. SARS-CoV-2 vaccination should be required to practise medicine in Canada. CMAJ. 2021;193(47):E1816-E1817doi: 10.1503/cmaj.211839.
McRae, A. D., & Laupacis, A. (2021). SARS-CoV-2 vaccination should be required to practise medicine in Canada. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 193(47), E1816-E1817. https://doi.org/10.1503/cmaj.211839
McRae, Andrew D, and Laupacis, Andreas. "SARS-CoV-2 vaccination should be required to practise medicine in Canada." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 193,47 (2021): E1816-E1817. doi: https://doi.org/10.1503/cmaj.211839
McRae AD, Laupacis A. SARS-CoV-2 vaccination should be required to practise medicine in Canada. CMAJ. 2021 Nov 29;193(47):E1816-E1817. doi: 10.1503/cmaj.211839. Epub 2021 Nov 09. PMID: 34753806; PMCID: PMC8654896.
Copy Download .nbib Format: NLM
[No title available]

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Sholzberg M, Arnold DM, Laupacis A.
PMID: 34226274
CMAJ. 2021 Jul 05;193(26):E1031-E1033. doi: 10.1503/cmaj.210882-f.

No abstract available.

Cite
Sholzberg M, Arnold DM, Laupacis A. Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin. . CMAJ. 2021;193(26):E1031-E1033doi: 10.1503/cmaj.210882-f.
Sholzberg, M., Arnold, D. M., & Laupacis, A. (2021). Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin. . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 193(26), E1031-E1033. https://doi.org/10.1503/cmaj.210882-f
Sholzberg, Michelle, et al. "Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin." . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 193,26 (2021): E1031-E1033. doi: https://doi.org/10.1503/cmaj.210882-f
Sholzberg M, Arnold DM, Laupacis A. Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin. . CMAJ. 2021 Jul 05;193(26):E1031-E1033. doi: 10.1503/cmaj.210882-f. French. PMID: 34226274; PMCID: PMC8248567.
Copy Download .nbib Format: NLM
[No title available]

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Bayoumi A, Laupacis A.
PMID: 34844946
CMAJ. 2021 Nov 29;193(47):E1826-E1827. doi: 10.1503/cmaj.211617-f.

No abstract available.

Cite
Bayoumi A, Laupacis A. Des critères d’assurance désuets empêchent le remboursement de soins fondés sur des données probantes. . CMAJ. 2021;193(47):E1826-E1827doi: 10.1503/cmaj.211617-f.
Bayoumi, A., & Laupacis, A. (2021). Des critères d’assurance désuets empêchent le remboursement de soins fondés sur des données probantes. . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 193(47), E1826-E1827. https://doi.org/10.1503/cmaj.211617-f
Bayoumi, Ahmed, and Laupacis, Andreas. "Des critères d’assurance désuets empêchent le remboursement de soins fondés sur des données probantes." . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 193,47 (2021): E1826-E1827. doi: https://doi.org/10.1503/cmaj.211617-f
Bayoumi A, Laupacis A. Des critères d’assurance désuets empêchent le remboursement de soins fondés sur des données probantes. . CMAJ. 2021 Nov 29;193(47):E1826-E1827. doi: 10.1503/cmaj.211617-f. French. PMID: 34844946; PMCID: PMC8654894.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries